Palatin Technologies (PTN) Tax Provisions (2010 - 2023)

Palatin Technologies' (PTN) quarterly Tax Provisions came in at -$9.3 million in Q2 2023, down 300.0% on a QoQ basis from $4.7 million in Q4 2022.

Palatin Technologies (PTN) Tax Provisions (2010 - 2023) Analysis & Trends

Palatin Technologies (PTN) has 8 years of Tax Provisions data on file, last reported at -$9.3 million in Q2 2023.

Quarterly Tax Provisions changed N/A year-over-year to -$9.3 million in Q2 2023, while the trailing twelve-month figure through Jun 2024 was -$9.3 million (down 100.0% YoY) and the FY2023 annual result came in at -$4.7 million, changed N/A from the prior year.
Tax Provisions retreated to -$9.3 million in Q2 2023, from $4.7 million in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $4.7 million in Q4 2022 to a low of -$9.3 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Palatin Technologies	40.37 Mn	40.37 Mn	-	-

Download Data